Hni (HNI) EBITDA (2009 - 2026)

Hni (HNI) has 18 years of EBITDA data on file, last reported at -$36.4 million in Q2 2026.

• On a quarterly basis, EBITDA fell 249.18% year-over-year to -$36.4 million in Q2 2026; TTM through Apr 2026 was $65.2 million, a 67.61% decrease from a year earlier, with the FY2026 full-year figure at $126.0 million, down 38.98% from the prior year.
• EBITDA for Q2 2026 stood at -$36.4 million, down from -$31.2 million in the prior quarter.
• Over the last five years, EBITDA for HNI reached as high as $81.9 million in Q4 2022 and fell as low as -$36.4 million in Q2 2026.
• Historically, EBITDA has averaged $33.2 million across 5 years, with a median of $30.3 million in 2022.
• Across the five-year window, EBITDA soared 1583.33% in 2024 and slumped 249.18% in 2026, its largest moves.
• Year by year, EBITDA stood at $23.0 million in 2022, then jumped by 33.48% to $30.7 million in 2023, then soared by 77.85% to $54.6 million in 2024, then climbed by 18.32% to $64.6 million in 2025, then slumped by 156.35% to -$36.4 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$36.4 million in Q2 2026, -$31.2 million in Q1 2026, and $64.6 million in Q3 2025.